Opinion: Since the CDC’s mid-May guidance on wearing masks, we’re no longer all in this together
Before there were magnificently effective Covid-19 vaccines, “We’re all in this together” was a crucial…
Category: Medicine
Opinion: Physicians, mental illness, and the problem with ‘passing’
My patient sits with her back hunched, eyes fixed on the taupe industrial carpet as…
How a 3D-printed graft could speed healing of ruptured eardrums
In the weeks that followed the 2013 Boston Marathon bombing, doctors saw a flood of…
STAT+: Expert panel votes down Fibrogen’s anemia pill due to safety risks, making U.S. approval unlikely
A panel of outside experts convened by the Food and Drug Administration concluded Thursday that…
.jpg)
STAT+: Expert panel votes unanimously that Biogen Alzheimer’s drug doesn’t offer patient benefits
A prominent panel of medical experts unanimously voted that there is no evidence to suggest…
Listen: The FDA’s future, Biden’s tight ship, & the latest Aduhelm twist
Who’s going to run the FDA? Why isn’t the Biden administration leakier? And what if…
NIH’s Francis Collins: For Biden’s new research agency to succeed, it should prepare for some projects to fail
WASHINGTON — Francis Collins is ready for the National Institutes of Health to fail spectacularly….
By creating mouse eggs entirely from scratch, researchers raise the prospect of a futuristic fertility treatment
The tiny clump of mouse cells didn’t look like an ovary. For one thing, it…
STAT+: DeepMind and and a rival release dueling code for protein-folding AI
Computational biologists have been on tenterhooks for the past seven months, ever since DeepMind took…
A slice of Apple’s health research, Teladoc for Teams, & combating health misinfo
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Are Blue Light Glasses Worth It? 6 Benefits Your Eyes Will Thank You For
The increased dependence on gadgets has led to the increased exposure of our eyes to…
STAT+: U.K. issues record fine to drug makers for price gouging and collusion schemes
After a lengthy investigation, the U.K. antitrust regulator has fined several drug makers a record-setting…
STAT+: Pharmalittle: FDA head admits possible missteps in Alzheimer’s drug approval; two major health systems won’t administer Biogen drug
Top of the morning to you and a fine one, it is. Moderate temperatures and…
Opinion: Sickle cell disease and a pivotal moment to end health inequality
Covid-19 laid bare the long-standing vulnerability of minority and low-income communities in U.S. society and…
STAT+: The ins and outs of the rare, controversial way Medicare might pay for Biogen’s new Alzheimer’s drug
WASHINGTON — The Food and Drug Administration last month foisted a nearly impossible decision on…
STAT+: Apple provides narrow glimpse at research behind new walking steadiness feature
Apple is gearing up to release a new metric called Walking Steadiness aimed at preventing…
STAT+: Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal
WASHINGTON — Senate Democrats intend to include several drug pricing policies in their $3.5 trillion…
With fewer than 400 progeria patients worldwide, testing a CRISPR cure will be challenging
When Sammy Basso was diagnosed with progeria at 2, it seemed likely that the disease’s…
Researchers use machine learning to translate brain signals from a paralyzed patient into text
Assistive technologies such as handheld tablets and eye-tracking devices are increasingly helping give voice to…
FDA chief Janet Woodcock acknowledges agency may have misstepped in process leading up to Alzheimer’s drug approval
WASHINGTON — Acting Food and Drug Administration Commissioner Janet Woodcock acknowledged on Wednesday her agency…
How Do Workout Supplements Work In Your Body? 8 Facts You Need To Know
Get the most from your exercise routine with the help of workout supplements. But how…
STAT+: FDA scolds Amgen over a misleading ad that could deter use of biosimilar versions of its drug
In an embarrassing rebuke, the Food and Drug Administration has scolded Amgen (AMGN) over a…
U.S. overdose deaths hit record 93,000 in 2020 during pandemic
NEW YORK — Overdose deaths soared to a record 93,000 last year in the midst…
STAT+: Pharmalittle: Half-dozen big insurers won’t cover new Alzheimer’s drug; Medicaid could spend up to $2.2 billion on the Biogen drug
Good morning, everyone, and how are you today? The sun is trying to peek through…
Opinion: Listen: An OB-GYN on the maternal mortality crisis in the U.S.
Why do more women die in and after childbirth in the U.S. than in any…
STAT+: ‘’This is unprecedented’: Several private insurers won’t cover Biogen’s Alzheimer’s drug
At least half-a-dozen private health insurers in some of the nation’s largest states are balking…
Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too
While Covid-19 struck a blow to a vast number of clinical trials around the world,…
Opinion: Vaxxed or axed: To protect patients, every health care worker must be vaccinated
Masks are off. Theaters and indoor dining are back. Life seems to be returning to…
My pregnancy made me fear for my career as a physician. It doesn’t have to be that way
I cried when I found out I was pregnant with my second child. While I…
COVID: Seven Reasons Mask Wearing In The West Was Unnecessarily Delayed
Masks help prevent the spread of SARS-CoV-2, the virus that causes COVID-19, yet masking policies…
COVID-19 Vaccine Boosters: Is A Third Dose Really Needed?
Vaccination with two doses helps prevent infection, and in those that do still get infected,…
The world will not exit Covid-19 pandemic without booster shots, vaccine developer says
The world will not get the Covid-19 pandemic under control without using booster shots for…
Biden to nominate Atul Gawande for global health position
President Biden will nominate noted surgeon and writer Atul Gawande for a global health position…
STAT+: Insulin makers and pharmacy benefit managers must face racketeering claims in a lawsuit
A federal judge dropped allegations that three drug makers engaged in antitrust practices by scheming…
STAT+: ‘Aduhelm left room’: Lilly CEO eyes competition with Biogen Alzheimer’s drug
Though a rival’s Alzheimer’s drug reached the market first, the CEO of Eli Lilly spoke…
STAT+: Biogen’s new Alzheimer’s drug could cost Medicaid up to $2.2 billion a year
A pricey new Alzheimer’s drug already mired in controversy could cost Medicaid anywhere from $720…
Biden to nominate West Virginia’s Rahul Gupta as drug czar
WASHINGTON — President Biden will nominate Rahul Gupta, a March of Dimes executive and former…
Rest stop telehealth, a data aggregator gets buy-in, & the EHR time drain
Truveta scores $95 million, adds hospital partners Truveta, a company formed to aggregate patient data…
STAT+: Pharmalittle: Medicare starts coverage review for Biogen Alzheimer’s drug; U.S. needs more data before deciding on Covid booster shot
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
Biden wants a drug pricing plan in 45 days. Who’s going to write it?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Patient data company Truveta raises $95 million, secures new hospital partners
A company formed to aggregate and sell de-identified data on millions of American patients has…
STAT+: If everyone already knows about a new biotech startup, why does it ‘launch’?
Biotech companies often linger in a corporate version of Schrödinger’s box — of existence and…
Are COVID-19 Vaccine Passports Fair?
It is increasingly likely that we will all need to show evidence of our COVID-19…
COVID: Lambda Variant Is Now In 29 Countries, But What Evidence Do We Have That It’s More Dangerous?
Lambda has now gone globetrotting. According to a recent World Health Organization (WHO) report, it…
Opinion: Managed care’s role in protecting women from childbirth-related complications
The coronavirus pandemic brought the importance of public health to the forefront of national attention….
‘The party is winding down’: States and insurers resurrect barriers to telehealth, putting strain on patients
Telemedicine is here to stay. But its free-for-all era may be coming to an end….
When and how will we know if we need Covid-19 booster shots?
There’s a lot we don’t yet know about the data behind Pfizer and BioNTech’s renewed…
STAT+: Medicare starts process that could limit access to Biogen’s new Alzheimer’s drug
WASHINGTON — Federal officials on Monday announced the agency will start a process that could…
Powerful House Democrats demand documents from Biogen about coordination with FDA on new Alzheimer’s drug
WASHINGTON — Two powerful House Democrats on Monday demanded documents from Biogen about the approval…
STAT+: Biden’s executive order would pause a Trump rule forbidding march-in rights to lower drug costs
In a little-noticed move, the Biden administration has hit the pause button on a rule…